Aging
Navigate
Back to articleFigure 2(2 of 7)
100%
Figure 2
Figure 2.Distribution of SLC10A3 transcription among different clinical groups. (A) age. (B) gender. (C) race. (D) WHO grade. (E) IDH mutation status. (F) 1p19q co-deletion. (G) laterality. (H) histological type. (I) primary therapy outcome.